Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.470
-0.030 (-2.00%)
Sep 4, 2026, 11:58 AM CET

Pila Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
69871023850109
Market Cap Growth
-20.18%-14.78%167.21%-23.60%-54.48%-
Enterprise Value
658699384577
Last Close Price
1.502.063.751.603.106.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
248.5176.94128.7826.0226.50152.22
PB Ratio
4.255.9219.335.725.233.61
P/TBV Ratio
4.255.9224.318.457.914.05

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
236.7075.98125.5626.2623.77106.59

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.20-1.09-0.93-0.89-0.76-0.93
Net Debt / EBITDA Ratio
0.492.290.701.120.823.05
Asset Turnover
0.030.100.110.150.090.04
Quick Ratio
4.5410.205.163.475.4918.72
Current Ratio
4.8110.275.213.485.5918.81
Return on Equity (ROE)
-194.16%-170.82%-188.57%-122.66%-134.47%-102.07%
Return on Assets (ROA)
-47.89%-44.75%-69.05%-41.32%-26.03%-31.14%
Return on Capital Employed (ROCE)
-48.40%-54.90%-154.10%-96.00%-93.30%-30.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-24.47%-19.61%-11.05%-26.08%-53.74%-15.72%
Buyback Yield / Dilution
-44.67%-35.92%-20.66%-22.29%-31.86%-30.89%